IndiaTickerSupha Pharmachem Ltd - 539561 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding The Order Passed By Hon'Ble National Company Law Appellate Tribunal (NCLAT) Principal Bench, New Delhi
BSE · exchange filing · pdf
Source filing Company dossier
Supha Pharmachem
BSE:SUPHA · ISIN INE549S01036
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Supha Pharmachem
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Supha Pharmachem Ltd - 539561 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Intimation Of Change In Insolvency Professional - Appointment Of Resolution Professional (RP) In Place Of Interim Resolution Professional (IRP)BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Post- Coc UpdateBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Corporate Insolvency Resolution Process (CIRP)-List of CreditorsBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Postponement Of Board Meeting Under Regulation 30 Of SEBI (LODR) Regulations, 2015BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Intimation Of Receipt Of Order From National Company Law Tribunal (NCLT)BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Submission Of Form A - PUBLIC ANNOUNCEMENTBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-Appointment of Interim Resolution Professional (IRP)BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Intimation Of Change In Registered OfficeBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Board Meeting Intimation for To Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December, 31, 2025 And Update On Trading WindowBSE · financial results · pdf
Source filing Supha Pharmachem Ltd - 539561 - Board Meeting Intimation for Rescheduled Of Board Meeting On 09.03.2026BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Board Meeting Intimation for Rescheduled Of Board Meeting On 25.02.2026BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Intimation Of Postponement And Rescheduling Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-DemiseBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Board Meeting Intimation for Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December, 31, 2025
BSE · financial results · pdf
Source filing Supha Pharmachem Ltd - 539561 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-Change of Company NameBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Supha Pharmachem Ltd - 539561 - Results - Financial Results For Quarter And Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing Supha Pharmachem Ltd - 539561 - Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Board Meeting Intimation for To Consider And Approve Unaudited Standalone And Consolidated Results For Quarter And Half Year Ended 30.09.2025BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Board Meeting Outcome for Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements), Regulation, 2015 For Outcome Of Board Meeting Held On Friday, 31St October, 2025
BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Appointment Of Mr. Rambhajan Vishwakarma And Mr. Vignesh Laxman GawdeBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Board Meeting Outcome for Meeting Held Today 22Nd September, 2025 Has Inter- Alia Considered, Approved And Taken On Record 1.Change Of Name Of The Company 2. Authorised Share Capital And 3. Further Capital RaisingBSE · exchange filing · pdf
Source filing Supha Pharmachem Ltd - 539561 - Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, Meeting Of The Board Of Directors Scheduled On 22/09/2025BSE · exchange filing · pdf
Source filing